
Biohub, supported by Mark Zuckerberg and Priscilla Chan, has launched a new open-source model for protein biology. The model, known as ESMFold2, is designed to predict and design proteins, offering state-of-the-art performance that surpasses AlphaFold. It has already demonstrated success in creating binders for cancer and immune disease targets. This development could significantly speed up drug discovery processes, making advanced molecular tools more accessible to researchers globally.
Read originalEarlier coverage that leads up to this article, and what followed. Lines connect each piece to the closest one after it, converging here.
MIT News AI · March 26, 2026 · Background
MIT News AI · April 17, 2026 · Related
The Rundown AI · April 30, 2026 · Related
AI News · August 7, 2026 · Background
The Rundown AI · August 20, 2026 · Background